Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancer

Donna O. Debets(Utrecht University), Maarten Altelaar(Utrecht University)
Cell Reports Medicine
October 1, 2023
Cited by 16


Related Papers